Roche’s TIGIT flop prompts GSK, iTeos to reevaluate next steps for rival drugnews2022-05-13T08:55:05+00:00May 13th, 2022|FierceBiotech|
Chutes & Ladders—Moderna CFO Gomez departs after just one day following unearthed investigationnews2022-05-12T17:24:57+00:00May 12th, 2022|FierceBiotech|
Bristol Myers provides Bridge over troubled water with $905M deal to enter SHP2 racenews2022-05-12T12:58:21+00:00May 12th, 2022|FierceBiotech|
After 20 years, Boehringer vet hits the exit to become CEO at autoimmune biotech SciRhomnews2022-05-12T11:47:42+00:00May 12th, 2022|FierceBiotech|
Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib datanews2022-05-12T01:55:41+00:00May 12th, 2022|FierceBiotech|
Caribou ready to uncork the chardonnay thanks to first-in-human CAR-T resultsnews2022-05-11T19:19:48+00:00May 11th, 2022|FierceBiotech|
Former Immunomedics CFO Usama Malik indicted for insider trading, pledging to dispute ‘false and speculative narrative’ at trialnews2022-05-11T17:51:04+00:00May 11th, 2022|FierceBiotech|
Welcome to new (Bio) Haven: CEO hopes to strike gold twice with remaining R&D crew after Pfizer dealnews2022-05-11T14:45:42+00:00May 11th, 2022|FierceBiotech|
Novo Nordisk, Flagship’s forward-thinking partnership aims to treat cardiometabolic, rare diseasesnews2022-05-11T14:37:58+00:00May 11th, 2022|FierceBiotech|
Bioasis, Neuramedy to cross blood-brain barrier together in $72M licensing dealnews2022-05-11T14:23:55+00:00May 11th, 2022|FierceBiotech|
